rologie i - European Congress of Virology

Recommendations

Info

5 th European Congress of VirologyWorkshop 8: “ANTIVIRAL THERAPY AND RESISTANCE TO ACUTE VIRAL INFECTION”Amphitheater, Level 0 (p. S41)Chairpersons: Johan NEYTS (Leuven, BELGIUM), Manuel ROSA-CALATRAVA (Lyon, FRANCE)16h15 – 16h45 Keynote: Antiviral Therapy and Resistance during acute viral infectionCharles BOUCHER (Rotterdam, THE NETHERLANDS)16h45 – 17h00 Potent inhibition of diverse Coronaviruses by targeting membrane bound viral RNA synthesisEveline KINDLER (St. Gallen, SWITZERLAND)17h00 – 17h15 Discovery of low molecular weight compounds inhibiting Chikungunya virus RNA replicationTero AHOLA (Helsinki, FINLAND)17h15 – 17h30 Humanized antibodies able to protect mice from tick borne encephalitisNina TIKUNOVA (Novosibirsk, RUSSIA)17h30 – 17h45 Characterization of human cytomegalovirus microRNA temporal expression profile and targetprediction by dynamic expression analysis, Marta TREVISAN (Padova, ITALY)17h45 – 18h00 Non liposomal delivery of anti-rabies virus siRNAs counteracts viral growth and spread in vitroTobias HALBACH (Munich, GERMANY)18h00 – 18h15 Inhibition of Pyrimidine Biosynthesis Pathway suppresses viral growth through innate immunityPierre Olivier VIDALAIN (Paris, France)WORKSHOP 24: “TYPING OF VIRUSES (MOLECULAR EPIDEMIOLOGY, TAXONOMY)”Room Prestige Gratte-Ciel, Level 2 (p. S43)Chairpersons: Anna PAPA (Thessaloniti, GREECE), Marie ROQUE-AFONSO (Paris, FRANCE)16h15 – 16h45Keynote: Genome diversity and evolution of vector-borne viruses, Luisa BARZON (Padova, ITALY)16h45 – 17h00 Mumps outbreak in the Netherlands, 2010-2012, Sigrid GOUMA (Bilthoven, THE NETHERLANDS)17h00 – 17h15 Molecular epidemiology of Hepatitis A virus in France, 2004-2012, Muriel MACÉ (Villejuif, FRANCE)17h15 – 17h30 Prevalence of human enterovirus and parechovirus genotypes in Amsterdam between 20072011 and comparison to surveillance data, Katja WOLTHERS (Amsterdam, THE NETHERLANDS)17h30 – 17h45 Characterization of complete rotavirus genomes using a single reverse transcriptionpolymerase chain reaction (RT PCR), Christian KOEHLER (Leipzig, GERMANY)17h45 – 18h00 First report on rotavirus genotypes from the Democratic Republic of São Tomé and Príncipe:high prevalence of G8P[6] genotype, Claudia ISTRATE (Lisbon, PORTUGAL)18h00 – 18h15 Taxonomy of Circoviridae: restructuring and expansion, Philippe BIAGINI (Marseille, FRANCE)WORKSHOP 27: “NEUROTROPIC VIRUSES” Room Tête d’Or, Level 1 (p. S45)Chairpersons: Tomas BERGSTROM (Gothenburg, SWEDEN), Monique LAFON (Paris, FRANCE)16h15 – 16h45 Keynote: Neurotropic Viruses, John FAZAKERLEY (Surrey, UNITED KINGDOM)16h45 – 17h00 Viral DNA containing PML NBs (DCP NBs) are a hallmark of the nuclear associated antiviralresponse controlling the latency of a herpesvirus, Patrick LOMONTE (Villeurbanne, FRANCE)17h00 – 17h15 Molecular interactions of tick borne encephalitis virus with human neural cellsDaniel RUZEK (Brno, CZECH REPUBLIC)17h15 – 17h30 Understanding the role of NS1 protein in the neuropathogenicity of Japanese encephalitis virus(Flaviviridae), Melissanne DE WISPELAERE (Paris, FRANCE)17h30 – 17h45 Activation of the potentially neuropathogenic HERV W/MSRV type endogenous retrovirusduring severe infectious mononucleosis and past Epstein Barr virus infection: the missing linkwith multiple sclerosis? Antonina DOLEI (Sassari, ITALY)17h45 – 18h00 Perturbation of neuronal signaling pathways by the rabies virus, Nicolas WOLFF (Paris, FRANCE)18h00 – 18h15 Infection and crossing of an in vitro cellular model of human blood brain barrier by a largearray of neurotropic enteroviruses, Romain VOLLE (Clermont Ferrand, FRANCE)18h15 – 20h00 GET TOGETHER AND POSTER SESSION Forum 5 & 6, Level -2Virologie, Vol. 17, supplément 2, septembre 2013S21
Scientific Programme -Thursday 12 th September 201308h30 – 10h30 WORKSHOP SESSIONSWORKSHOP 5: “VIRAL (IMMUNO)PATHOGENESIS” Room Prestige Gratte-Ciel, Level 2 (p. S47)Chairpersons: Branka HORVAT (Lyon, FRANCE) & Thomas MERTENS (Ulm, Germany)08h30 – 09h0009h00 – 09h1509h15 – 09h3009h30 – 09h4509h45 – 10h0010h00 – 10h1510h15 – 10h30Keynote: Vaccine induced immunity to influenza: Some considerationsGuus F. RIMMELZWAAN (Rotterdam, THE NETHERLANDS)Consumptive coagulopathy and tissue fibrin deposition in seasonal, pandemic and highlypathogenic avian influenza infection, Marco GOEIJENBIER (Rotterdam, THE NETHERLANDS)Bioluminescence Imaging of Cytomegalovirus (CMV) Dissemination in the Guinea Pig ModelDemonstrates a Novel Hot Spot for Infection & Impaired Tropism Associated with a Viral Gprotein Coupled Receptor Mutant, Alistair MCGREGOR (College Station, USA)Herpes Simplex Virus Type 1 infection of enteric nervous system causes neuronal damage throughtoll like receptor 2 mediated macrophages recruitment, Ignazio CASTAGLIUOLO (Padova, ITALY)Ross River Virus is able to persist in tissues of infected macaque similarly to Chikungunyavirus despite lower viremia during acute phaseLaurence DUPUIS MAGUIRAGA (Fontenay aux Roses, FRANCE)MicroRNA expression signatures in chronic viral hepatitis progressionAlessandro SINIGAGLIA (Padova, ITALY)Characterization and functional analysis of the murine gammaherpesvirus 68 microRNAsAmr BAYOUMY (Edinburgh, UNITED KINGDOM)WORKSHOP 12: “VIRAL GENE EXPRESSION – TRANSCRIPTION, TRANSLATION” Room Tête-d’Or, Level 1 (p. S49)Chairpersons: Richard ELLIOTT (Glasgow, UNITED KINGDOM) & Peter ROTTIER (Utrecht, THE NETHERLANDS)08h30 – 09h0009h00 – 09h1509h15 – 09h3009h30 – 09h4509h45 – 10h0010h00 – 10h1510h15 – 10h30Keynote: Norovirus translation: a novel paradigm for viral protein synthesisIan GOODFELLOW (Cambridge, UNITED KINGDOM)Identification of an RNA translational regulator element at the 3’ end of the TGEV genomeFernando ALMAZAN (Madrid, SPAIN)TIA 1 is a cellular restriction factor for tick borne encephalitis virus that binds viral RNAand is recruited to perinuclear sites of viral replication, Alessandro MARCELLO (Trieste, ITALY)Structure of the full length hepatitis C virus IRES in solution, Marc JAMIN (Grenoble, FRANCE)A dynamic G quadruplex region regulates the HIV 1 LTR promoter, Rosalba PERRONE (Padua, ITALY)A transcriptional pre initiation complex encoded by beta and gamma herpesviruses requiredfor late viral gene expression, Henri GRUFFAT (Lyon, FRANCE)HCMV pp150 constitutes a Cyclin A2 CDK dependent switch controlling the cell cycle anddifferentiation dependent onset of lytic gene expression, Boris BOGDANOW (Berlin, GERMANY)S22Virologie, Vol. 17, supplément 2, septembre 2013
Page 3 and 4: Contents5 th European Congress of V
Page 5 and 6: i r o l o g i eList of Keynote Spea
Page 7 and 8: i r o l o g i eList of Chairpersons
Page 9 and 10: i r o l o g i eWelcomeWelcome to th
Page 11 and 12: 5 th European Congress of VirologyY
Page 13 and 14: i r o l o g i eExhibitorsThe indust
Page 15: i r o l o g i eFacilities for the 5
Page 18 and 19: i r o l o g i eGeneral Information
Page 20 and 21: PROGRAMME AT A GLANCEWednesday 11th
Page 24 and 25: 5 th European Congress of VirologyW
Page 32 and 33: Scientific Programme -Saturday 14 t
Page 34 and 35: 5 th European Congress of Virology1
Page 48 and 49: 5 th European Congress of VirologyT
Page 54 and 55: 5 th European Congress of VirologyR
Page 58 and 59: 5 th European Congress of Virologyw
Page 64 and 65: 5 th European Congress of Virologyt
Page 70 and 71: 5 th European Congress of VirologyA
Page 72 and 73:
5 th European Congress of Virologyp
Page 74 and 75:
5 th European Congress of VirologyR
Page 76 and 77:
5 th European Congress of VirologyF
Page 78 and 79:
Page 80 and 81:
5 th European Congress of Virologyc
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
5 th European Congress of Virologyt
Page 88 and 89:
5 th European Congress of VirologyH
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
5 th European Congress of VirologyS
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
5 th European Congress of VirologyA
Page 106 and 107:
5 th European Congress of Virology1
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Virologie 2013, 17 (supplément 2)
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
5 th European Congress of VirologyH
Page 128 and 129:
5 th European Congress of Virologys
Page 130 and 131:
Page 132 and 133:
5 th European Congress of Virologyf
Page 134 and 135:
5 th European Congress of VirologyE
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
5 th European Congress of Virologyi
Page 146 and 147:
5 th European Congress of Virologyr
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
5 th European Congress of VirologyB
Page 162 and 163:
5 th European Congress of Virologyr
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
5 th European Congress of VirologyI
Page 170 and 171:
Page 172 and 173:
5 th European Congress of Virologya
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
5 th European Congress of VirologyV
Page 182 and 183:
Page 184 and 185:
5 th European Congress of Virologyw
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
5 th European Congress of Virologyn
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
5 th European Congress of VirologyT
Page 200 and 201:
5 th European Congress of Virology(
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
5 th European Congress of Virologyo
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
5 th European Congress of Virology(
Page 224 and 225:
Page 226 and 227:
5 th European Congress of Virologyn
Page 228 and 229:
Page 230 and 231:
5 th European Congress of Virologyo
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
5 th European Congress of Virologyh
Page 250 and 251:
Page 252 and 253:
5 th European Congress of VirologyC
Page 254 and 255:
5 th European Congress of VirologyM
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
5 th European Congress of VirologyM
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
5 th European Congress of Virologyu
Page 274 and 275:
5 th European Congress of VirologyO
Page 276 and 277:
5 th European Congress of Virologys
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
5 th European Congress of VirologyB
Page 290 and 291:
5 th European Congress of VirologyD
Page 292 and 293:
5 th European Congress of VirologyG
Page 294 and 295:
5 th European Congress of VirologyJ
Page 296 and 297:
5 th European Congress of VirologyL
Page 298 and 299:
5 th European Congress of VirologyN
Page 300 and 301:
Page 302 and 303:
Page 304 and 305:
5 th European Congress of VirologyW
show all

rologie i - European Congress of Virology

Create successful ePaper yourself

Delete template?

Save as template?